From Book News, Inc.

Urologists and pathologists share insight on their specialties that clinicians could factor into decisions regarding the assessment and treatment of bladder cancer. Especially in areas where there is no wide agreement, contributors were teamed up who had different and often conflicting ideas. The resulting 17 studies look at the demographic and epidemiologic aspects, diagnostic imaging in urothelial cancer, using tumor markers and current concepts on clinical applicability, radical cystectomy and pelvic lymphadenectory in the treatment of infiltrative bladder cancer, current concepts of urinary diversion in men and women, and other topics.Book News, Inc.

Book Info

Mount Sinai School of Medicine, New York, NY. Presents state of the art in the assessment and management of bladder cancer, and translates scientific findings into everyday clinical practice. Integrates differing opinions on controversial issues. For clinicians and clinical investigators. DNLM: Bladder Neoplasms-diagnosis.

Preface
List of Contributors
1 Demographic and Epidemiologic Aspects of Bladder Cancer 1
2 Biology and Molecular Aspects of Development and Progression of Bladder Cancer 25
3 Diagnosis of Bladder Cancer 57
4 Diagnostic Imaging in Urothelial Cancer 85
5 Urinary Cytology and its Role in Diagnosis and Monitoring in Urothelial Carcinoma 103
6 The Use of Tumor Markers in Bladder Cancer and Current Concepts on Clinical Applicability 133
7 Pathologic Assessment of Bladder Cancer and Pitfalls in Staging 149
8 Intravesical Chemotherapy in the Treatment of Superficial Bladder Cancer 183
9 Use of Intravesical BCG in Treatment of Superficial Bladder Cancer 225
10 Radical Cystectomy and Pelvic Lymphadenectomy in the Treatment of Infiltrative Bladder Cancer 267
11 Considerations in the Use of Neoadjuvant and Adjunctive Systemic Chemotherapy in Treatment of Invasive Bladder Cancer by Cystectomy 309
12 Clinical Situations for the Role of Radiation Therapy in the Treatment of Bladder Cancer 327
13 Current Concepts of Urinary Diversion in Men 343
14 Current Concepts in Urinary Diversion in Women 367
15 Current Prospects for the Use of Molecular Markers in Treatment of Bladder Cancer by Cystectomy or Bladder-Conserving Approaches 381
16 New Possibilities in Systemic Treatment for Metastatic Bladder Cancer 393
17 Statistical Considerations in the Phase II Evaluation of New Therapies 423
Index 439